The return of startup investing - Verve Ventures
  • Exits allow startup investors to realize the value of their holdings and to achieve a return on their investments.
  • An exit is a sign that a startup is mature, successful, and valuable enough for a buyer.
  • The number and size of exits are an indication of the strength of a startup ecosystem and its ability to produce, nurture and grow exciting and fast-growing companies.
  • Successful exits also have an intangible value, inspiring budding entrepreneurs to try their luck. Every exit transports the message that you can succeed if you try hard enough.

The number of exits has increased markedly since 2013 compared to the time before. There were, on average, around 32 exits per year in the period between 2014 and 2020. In 2020 we counted 37. The number increased significantly in 2021 and reached 91 exits.

Global M&A activity hit USD 5 trillion, an all-time high, breaking a record set in 2007 (of USD 4.4 trillion). In Europe, the number was up 50% compared to 2020. Technology and healthcare were the sectors that contributed most to the global M&A boom.

Invest in Startups

As one of Europe’s most active venture capital investors, we grant qualified private investors access to top-tier European startups. With investments starting at EUR/CHF 10’000, you can build your own tailored portfolio over time and diversify across stages and sectors.

The return of startup investing - Verve Ventures

Software startups achieved the highest number of exits. In 2021, exits of digital companies were almost three times as numerous as their long-term average. The median exit price was CHF 48 million.
Exits of hardware startups take longer to manifest and are less frequent. However, the median exit price in this segment is a lot higher than for digital startups and amounts to CHF 170 million.
For biotech startups, the motto is “go big or go home”. Either these startups fail because the proposed new treatments don’t show the efficacy that was expected, or they successfully complete their clinical trials with promising data, and get bought for a lot of money.

The return of startup investing - Verve Ventures

Invest in Startups

As one of Europe’s most active venture capital investors, we grant qualified private investors access to top-tier European startups. With investments starting at EUR/CHF 10’000, you can build your own tailored portfolio over time and diversify across stages and sectors.